Where the World’s Best Science
Becomes Medicine
A scalable hub-and-spoke engine for global drug development
Our Approach
K2 Therapeutics is a biotech company built for global impact, with search and development capabilities unconstrained by modality or geography. We identify the world’s most innovative assets and translate them into great medicines through a disciplined development approach and lead by experienced drug developers. Our focus is on high-potential first- and best-in-class assets with meaningful potential for patient impact worldwide.
About us
Our Advantages / Our Ambition
Proven legacy
30+ years track record of identifying groundbreaking technologies and developing next-generation life-saving medicines
Unmatched experience
Founding leadership team with expertise in the most innovative areas of biotechnology, capabilities across the entire drug development process and deep experience in navigating the complex regulatory landscape globally
Global reach
International footprint and broad ecosystem to source the world’s best science and efficiently advance it through cross-regional clinical trials
Development speed
with rigor
Advance programs through clinical proof of concept with disciplined execution and early attention to manufacturing, translational science, and commercial potential.
Hub-and-spoke
efficiency at scale
Centralized strategy and leadership combined with parallel, distributed development across multiple assets to drive efficiency, focus, and portfolio diversification.
Cross-regional collaboration for global-ready evidence
Cross-regional clinical execution across major geographical markets delivers globally relevant evidence, early derisking, and accelerates regulatory outcomes.
Proven legacy
30+ years track record of identifying groundbreaking technologies and developing next-generation life-saving medicines
Unmatched experience
Founding leadership team with expertise in the most innovative areas of biotechnology, capabilities across the entire drug development process and deep experience in navigating the complex regulatory landscape globally
Global reach
International footprint and broad ecosystem to source the world’s best science and efficiently advance it through cross-regional clinical trials
Ansbert Gadicke, M.D.
EXECUTIVE CHAIRMAN
Frank Neumann, M.D., Ph.D.
CHIEF MEDICAL OFFICER
Wu Jie, M.S.
CHIEF BUSINESS OFFICER
Jin Wang, M.D., Ph.D.
VP OF CLINICAL DEVELOPMENT
David Kolesky, Ph.D.
HEAD OF CORPORATE DEVELOPMENT
Grey Sieczkiewicz, J.D., Ph.D.
IP COUNSEL
Binsen Li, Ph.D.
HEAD OF INVESTMENT & BUSINESS DEVELOPMENT
Hao Xing, Ph.D.
DIRECTOR OF BUSINESS DEVELOPMENT
Latest news
View More
Contact us
Have questions about us or want to learn more?